United States bioinformatics market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing biotechnological procedures and techniques. Also, rising technical advancements like nucleic acid and protein sequencing, genetic engineering, and storage of the then found data and its analysis further drives the growth of the United States bioinformatics market in the upcoming five years. Rising demands for the biotechnological procedures for advancing medicine, finding the cure for diseases etc. also supports the growth of the United States bioinformatics market in the next five years.
Application of the tools of computation and analysis to collection and interpretation of the biological data is termed as bioinformatics. A conjugation of multiple fields like medicine, computer science, mathematics, physics, forms bioinformatics. Moreover, the storage of the human genome project data and other similar genomic projects aids to the growing requirements of bioinformatics. The storage of the genome mapping data helps in analyzing underlying genomes and thus translated protein information of any new species. Microorganisms like bacteria, virus, fungi have tendency to mutate rapidly. The infectious diseases thus caused often leads to the urgency for devising treatments and vaccines against the microbes. The recent pandemic is one such example that actively utilized functions of bioinformatics in formulating the genome mapping of the coronavirus and its strain along with the vaccine and the pharmaceuticals.
Prevalence of Rare Diseases Promises Market Growth
Rapid outbreaks of new diseases and growing prevalence of infectious diseases with unidentified strains of microorganisms, and their adversities drive the growth of the United States bioinformatics market in the upcoming five years. The definition of rare diseases in the country depends on the population it affects in a country or a region for a prolonged period of time. In the United States, if a disease affects less than 200,000 people it is categorized as a rare disease. In the recent times, the rare diseases along with the infections have grown rapidly and affected large population in the country.
Recent pandemic affected the worldwide population. In United States, over 81 million cases have been recorded in the country by March 2022 where 997,933 people died due to COVID-19. The United States was one of the few countries that came up with the vaccination and pharmaceuticals for the viral infection, and the use of bioinformatics for the purpose was a boon. Therefore, the prevalent nature of such infectious diseases would support the growth of the United States bioinformatics market in the next five years.
Technological Advancement Guides Market Growth
Growing advancement in the biotechnological procedures and processes drives the market growth. Moreover, the evolution of big data technology is also fueling the technical advancement in the bioinformatics field. Using the technology for the analysis of the protein structure, functions, and further predictive analysis is substantiating the growth of the United States bioinformatics market in the future five years. Moreover, developments in systems biology and genomic analysis of pharmaceuticals have helped personalized medicine to transit from disease-centered and reductionism-based medical practice to system-based, integrative, and human-centered care.
Furthermore, increasing investment for the research and advancement in the bioinformatic systems & services is another major factor aiding the growth of the United States bioinformatics market. In the year 2021, USD597.26 billion was spent over research and development in the healthcare sector. A large section was involved in pharmaceutical advancement and data storage regarding new protein translations, thus substantiating market growth in the country.
Click here to download the sample
Market Segmentation
The United States bioinformatics market is segmented by product & services, type, application, end user, competitional landscape, and regional distribution.
Company Profile
Illumina, Inc., Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., PerkinElmer Inc., QIAGEN Inc., 23AndMe, DataTrack International, Inc., Biovia-Dassault Systemes, Waters Corporation, SOPHiA GENETICS
| Attribute | Details |
| Base Year | 2021 |
| Historical Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | - Product & Services
- Type
- Application
- End User
|
| Regional scope | South region, Mid-West region, North-East region, and West region. |
| Key companies profiled | Illumina, Inc., Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., PerkinElmer Inc., QIAGEN Inc., 23AndMe, DataTrack International, Inc., Biovia-Dassault Systemes, Waters Corporation, SOPHiA GENETICS |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
